Rigel Pharmaceuticals Inc Tangible Net Worth Ratio
Rigel Pharmaceuticals Inc tangible net worth ratio. Rigel Pharmaceuticals Inc (RIGL) has a Tangible Net Worth Ratio of 77.9% as of June 2026. This metric is calculated by deducting intangible assets ($93.88 Million) from net assets ($425.65 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check RIGL strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Rigel Pharmaceuticals Inc (1999–2025)
Tangible net worth ratio of Rigel Pharmaceuticals Inc from 1999 to 2025. This chart shows how Rigel Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 25 annual periods from 1999 to 2025. As of June 2026, the ratio stands at 77.9%, reflecting net assets of $425.65 Million with intangible assets of $93.88 Million USD. See RIGL working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Rigel Pharmaceuticals Inc Tangible Net Worth Ratio by Year (1999–2025)
Rigel Pharmaceuticals Inc tangible net worth ratio by year from 1999 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Rigel Pharmaceuticals Inc from 1999 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Rigel Pharmaceuticals Inc (RIGL) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.7% | $391.48 Million | $24.75 Million | $513.59 Million | ▲ +817.9 pp |
| 2024 | -724.2% | $3.29 Million | $27.10 Million | $163.98 Million | ▼ -824.2 pp |
| 2021 | 100.0% | $30.37 Million | $0.00 | $167.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $34.03 Million | $0.00 | $110.38 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $53.81 Million | $0.00 | $147.57 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $109.88 Million | $0.00 | $139.11 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $100.65 Million | $0.00 | $119.11 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $55.03 Million | $0.00 | $78.13 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $91.38 Million | $0.00 | $131.75 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $128.25 Million | $0.00 | $154.13 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $208.25 Million | $0.00 | $226.06 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $289.10 Million | $0.00 | $310.04 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $236.15 Million | $0.00 | $257.11 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $166.13 Million | $0.00 | $186.69 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $109.87 Million | $0.00 | $140.74 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $104.17 Million | $0.00 | $143.86 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $82.18 Million | $0.00 | $115.79 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $87.23 Million | $0.00 | $113.24 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $108.59 Million | $0.00 | $147.67 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $52.30 Million | $0.00 | $78.82 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $39.97 Million | $0.00 | $55.52 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $25.44 Million | $0.00 | $44.34 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $28.94 Million | $0.00 | $46.45 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $49.01 Million | $0.00 | $64.26 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $756.00K | $0.00 | $17.17 Million | — |